UCB, IBM Collaborate to Personalize Care for Epilepsy Patients
Project will use big data and analytics to address pressing public health issue
-
Business
Featured Story
-
Marketing & Advertising
Featured Story
Sanofi Taps Jerome Bettis to Tackle Anaphylaxis
Bettis unveils new playbook for defending against severe allergic reactions and affected to take action
-
R&D
Featured Story
AstraZeneca Moves 3 Cancer Compounds to Phase III
First patient enrolled in Phase III clinical trial for moxetumomab pasudotox as a treatment for unresponsive or relapsed hairy cell leukemia patients
-
Therapeutics
Featured Story
FDA OKs Simponi for Ulcerative Colitis Indication
Simponi has already been approved by the FDA for the treatment of moderately to severely active rheumatoid arthritis
-
Pharmalot
Featured Story
The Risperdal Lawsuits Keep On Coming: Kentucky Sues J&J
Like a game of whack-a-mole, no matter how many times Johnson & Johnson attempts to put to rest lawsuits over the marketing of its Risperdal...
- Resources
- Directories
- Manny Awards
- Events
- Jobs
